Published in Diabetologia on September 01, 2001
Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA (2008) 2.28
Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol (2012) 1.99
Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst (2009) 1.52
The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med (2009) 1.35
Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr (2010) 1.16
Triglycerides and cardiovascular risk. Curr Cardiol Rev (2009) 1.12
Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci (2007) 1.10
Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension. Am J Physiol Heart Circ Physiol (2008) 1.06
Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice. Exp Diabetes Res (2011) 1.06
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol (2013) 0.96
Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS (2009) 0.95
Diabetic neuropathy in older adults. Clin Geriatr Med (2008) 0.94
Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes. Obesity (Silver Spring) (2008) 0.93
Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy. AIDS (2011) 0.91
Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice. PLoS One (2013) 0.90
Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688. Exp Diabetes Res (2009) 0.89
Association between diabetes mellitus with metabolic syndrome and diabetic microangiopathy. Exp Ther Med (2014) 0.88
Oxidized LDL and the metabolic syndrome. Future Lipidol (2008) 0.87
Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy? J Diabetes Res (2017) 0.87
Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. Exp Neurol (2012) 0.86
Excess body mass index loss predicts metabolic syndrome remission after gastric bypass. Diabetol Metab Syndr (2014) 0.85
Renal tubular transport and the genetic basis of hypertensive disease. Clin Exp Nephrol (2005) 0.85
Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status. Diabetes Care (2016) 0.84
The significance of screening for microvascular diseases in Chinese community-based subjects with various metabolic abnormalities. PLoS One (2014) 0.82
Glycemic load is associated with HDL cholesterol but not with the other components and prevalence of metabolic syndrome in the third National Health and Nutrition Examination Survey, 1988-1994. Int Arch Med (2009) 0.82
Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: The Taiwan Diabetes Study. Medicine (Baltimore) (2015) 0.82
Stress in obesity and associated metabolic and cardiovascular disorders. Scientifica (Cairo) (2012) 0.81
Relationship between Alcohol Consumption and Metabolic Syndrome according to Facial Flushing in Korean Males. Korean J Fam Med (2012) 0.80
Cardiometabolic risk profiles associated with chronic complications in overweight and obese type 2 diabetes patients in South China. PLoS One (2014) 0.79
The metabolic syndrome and severity of diabetic retinopathy. Clin Ophthalmol (2015) 0.79
Effect of high-fat diet on peripheral neuropathy in C57BL/6 mice. Int J Endocrinol (2014) 0.77
The metabolic vascular syndrome - guide to an individualized treatment. Rev Endocr Metab Disord (2016) 0.76
Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease (IHD) and Retinopathy. J Clin Diagn Res (2015) 0.76
Implication of Renal Aquaporin-3 in Fructose-Induced Metabolic Syndrome and Melatonin Protection. J Clin Diagn Res (2016) 0.75
Comparison of consumption behavior and appetite sensations among patients with type 2 diabetes mellitus after bariatric surgery. PeerJ (2017) 0.75
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population. JAMA Neurol (2016) 0.75
Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db mice. Nutr Res Pract (2012) 0.75
Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions. PLoS One (2015) 0.75
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med (1989) 3.38
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia (2009) 3.33
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol (1991) 2.43
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes (1996) 2.33
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia (2009) 2.25
The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med (1997) 2.20
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes (2000) 1.90
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care (2000) 1.76
Obesity and insulin resistance in humans: a dose-response study. Metabolism (1990) 1.74
Serum complement and familial combined hyperlipidemia. Atherosclerosis (1997) 1.64
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia (2009) 1.62
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia (2010) 1.52
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
Coffee consumption and the risk of latent autoimmune diabetes in adults--results from a Swedish case-control study. Diabet Med (2014) 1.51
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia (2008) 1.50
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49
Lipid intolerance in smokers. J Intern Med (1995) 1.48
Effect of muscular exercise on insulin secretion. Diabetes (1968) 1.48
Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes. Diabetologia (2004) 1.47
Extensive changes in the transcriptional profile of human adipose tissue including genes involved in oxidative phosphorylation after a 6-month exercise intervention. Acta Physiol (Oxf) (2014) 1.45
Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 1.44
Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes (2002) 1.43
Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia (2013) 1.39
Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med (1994) 1.36
Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation (2001) 1.35
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia (2007) 1.34
Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia (2009) 1.33
Changes in serum lipoprotein pattern induced by acute infections. Metabolism (1988) 1.32
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia (2011) 1.32
Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet (2002) 1.31
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia (2011) 1.31
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest (1997) 1.30
GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes (1994) 1.30
Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia (2009) 1.29
Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia (2008) 1.28
Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest (1997) 1.27
A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia (2009) 1.27
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol (2001) 1.23
A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia (2010) 1.22
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet (1999) 1.21
Volatile organic compounds and formaldehyde as explaining factors for sensory irritation in office environments. J Occup Environ Hyg (2009) 1.21
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis (1996) 1.20
Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol (1991) 1.20
Lipoprotein lipase in diabetes. Diabetes Metab Rev (1987) 1.19
Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism (1978) 1.18
Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia (2009) 1.18
Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia (2012) 1.17
Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol (1997) 1.17
Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation (1996) 1.17
Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes. Scand Cardiovasc J (2001) 1.16
Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia (1996) 1.16
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis (1999) 1.16
Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol (1993) 1.15
Metabolic effects of metformin in patients with impaired glucose tolerance. Diabet Med (2001) 1.15
Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab (2000) 1.15
ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab (2000) 1.14
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res (1989) 1.13
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes (1998) 1.11
The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia (2008) 1.11
Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J (1999) 1.11
Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J (1987) 1.10
γ-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes. Diabetologia (2012) 1.10
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation (2000) 1.10